&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-03, 20:25

Music Licensing, Inc. (OTC: SONG) Announces Acquisition of Royalty Rights to "Thank God I Got It" by Desiigner, Bolstering Its Diverse and Star-Studded Portfolio

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-22, 03:15

Olaplex Holdings, Inc. Announces Participation in the Barclays 17th Annual Global Consumer Staples Conference on September 4th
Tony Loman

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-15, 20:47

Matmerize, Inc., Introduces “ASKPOLY” – A Language Model Based Polymer Expert
Basil Slack

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-07-16, 20:26

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis

Basil Slack

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-07-10, 07:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal

Jillian Pearce

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-07-09, 07:00

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-05-28, 20:00

Music Licensing, Inc. (OTC: SONGD) Acquires Prestigious Royalty-Generating IP Stake in "Goodnight Gotham" by Rihanna
Jannie Boothby

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-05-20, 20:07

Music Licensing, Inc. (OTC: SONGD) Receives Third Royalty Payment from Stake in Listerine "Mouthwash" Antiseptic

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-05-06, 19:15

Exodus Movement, Inc. Announces Uplist to NYSE American Exchange

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-04-04, 20:05

Matmerize, Inc. and CJ Biomaterials Partner to Utilize Innovative AI Technology to Advance Sustainable Polymer Solutions
Jannie Boothby

Popular Posts